Skip to main content
. 2007 Jun 14;13(22):3084–3089. doi: 10.3748/wjg.v13.i22.3084

Table 2.

Immunogenicity data of GeneVac-B, Engerix B and Shanvac B in babies born to HBsAg positive mothers

Parameters 1st dose 2nd dose 3rd dose After one year
Group-I- GeneVac-B
No. of infants 58 48 48 35
Seroconversion 57.10% 94.20% 100% 100%
Seroprotection 22.80% 82.80% 100% 100%
GMT (mIu/mL) 11.6 35.4 93.5 226.7
Group-II- Engerix B
No. of infants 50 43 38 21
Seroconversion 57.10% 90.00% 100% 100%
Seroprotection 19.00% 71.40% 100% 100%
GMT (mIu/mL) 8.4 24.4 80.9 197.9
Group-III Shanvac B
No. of infants 50 45 32 12
Seroconversion 50% 91.60% 100% 100%
Seroprotection 16.60% 66.60% 100% 100%
GMT (mIu/mL) 8 18.6 72.55 173.6